Skip to main content
About ZAPI

The new Zoonoses Anticipation and Preparedness Initiative (ZAPI), part of the Innovative Medicines Initiative (IMI) public-private partnership, aims to enable swift response to major new infectious disease threats in Europe and throughout the world by designing new manufacturing processes (up to large scale) for delivering effective control tools (vaccines, antibodies/antibody-like molecules) against (re-)emerging zoonotic diseases with pandemic potential within a few months after the occurrence of first cases.

illustration of people and animals
About Zoonoses

A zoonotic disease (or zoonosis) is any disease or infection that is transmissible from animals to humans. Zoonoses may be caused by viruses, bacteria, fungi and parasites. Example of zoonoses are Avian Influenza, Swine Influenza, Crimean-Congo hemorrhagic fever, Ebola, Rift Valley Fever, SARS,  Salmonellosis, Anthrax, Brucellosis, leptospirosis, plague, toxoplasmosis...

About Imi

The Innovative Medicines Initiative (IMI)

The ZAPI project is funded by the Innovative Medicines Initiative (IMI), a large-scale public-private partnership between the European Union and the pharmaceutical industry association EFPIA.

Monday, November 14, 2016
ZAPI present at IMI Stakeholder Forum 2016

ZAPI's coordinator, Jean-Christophe Audonnet attended the IMI Stakeholder Forum 2016 which took place in Brussels on 28 and 29 September 2016. 
This year’s Stakeholder Forum was attended by 377 people, and counted 97 unique webcast connections from all over the world. 

Main menu